LobbyingSorrento Therapeutics lobbying by quarter
Sorrento Therapeutics's latest lobbying report covers Q3 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Consumer Issues/Safety/Protection and Pharmacy.
Sorrento Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $200K | 3 |
| Q1 2023 | $90K | 3 |
| Q2 2023 | $0 | 2 |
| Q3 2023 | $0 | 2 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Consumer protection and safety$105K · 4 reports
- Pharmacy$105K · 4 reports
- Health issues$50K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)5 reports
- HOUSE OF REPRESENTATIVES5 reports
- Executive Office of the President (EOP)4 reports
- Food & Drug Administration (FDA)4 reports
- SENATE4 reports
- White House Office4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Stonington Global | $210K | 4 quarters |
| ML Strategies | $80K | 2 quarters |
| Da Vinci Group | $0 | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| NICOLAS DAVID MUZIN | Senior Advisor and Deputy Chief of Staff, Senator Ted Cruz; Director of Coalitions, House Republican Conference; Chief of Staff and Senior Advisor, Congressman Tim Scott | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/10/17for Q3 2024 | Da Vinci Group | Under $5,000 |
| 24/07/18for Q2 2024 | Da Vinci Group | Under $5,000 |
| 24/04/17for Q1 2024 | Da Vinci Group | Under $5,000 |
| 24/01/18for Q4 2023 | Da Vinci Group | Under $5,000 |
| 23/10/19for Q3 2023 | Da Vinci Group | Under $5,000 |
| 23/10/03for Q3 2023 | Stonington Global | Under $5,000 |
| 23/07/18for Q2 2023 | Da Vinci Group | Under $5,000 |
| 23/07/05for Q2 2023 | Stonington Global | Under $5,000 |
| 23/04/20for Q1 2023 | ML Strategies | $30K |
| 23/04/19for Q1 2023 | Da Vinci Group | Under $5,000 |
| 23/03/27for Q1 2023 | Stonington Global | $60K |
| 23/01/20for Q4 2022 | ML Strategies | $50K |
| 23/01/17for Q4 2022 | Da Vinci Group | Under $5,000 |
| 23/01/09for Q4 2022 | Stonington Global | $150K |